All About Insulin Spray Beyond Diabetes

Intranasal insulin demonstrated faster walking and better cognitive functioning and memory in patients with and without type 2 diabetes.

Intranasal insulin spray increased the walking speed, and blood flows to the brain and decreased blood insulin in type 2 diabetes, while it improved decision making and verbal memory in people with and without type 2 diabetes. These findings are published in the Journal of Neurology.

What Is Inhaled Insulin?

Insulin - How it Works, Types, Administration, Precautions, Health Tips
Insulin is a natural hormone that controls our blood sugar. Learn about types of insulin and devices for delivery including insulin syringes, pens and insulin pumps.

‘Intranasal insulin should be tested for its possible utility as a treatment for type 2 diabetes and also for age-related functional decline.’

An estimated 25% of people older than 65 have type 2 diabetes, a condition in which the body cannot produce enough insulin to effectively manage blood sugar.

Insulin plays an important role in the brain, and people with prediabetes and diabetes are at increased risk of Alzheimer’s disease and cognitive decline.

Delivering insulin to the brain in the form of spray through the nose has shown to improve verbal memory and has emerged as a potential treatment for cognitive decline in the elderly.

Smart Insulin Patch may One Day Help Control Diabetes
Newly developed coin-sized smart insulin patch could one day help monitor blood glucose levels and deliver the required insulin dosage in a smart and convenient manner.

Recently, a team of scientists at Beth Israel Deaconess Medical Center (BIDMC) has assessed the long-term effects of intranasal insulin (INI) on cognition and gait in people with and without type 2 diabetes mellitus.

“Walking speed is an important clinical predictor of well-being in the elderly that correlates with cognitive decline, hospitalizations, disability, and death,” said Vera Novak.

New Pill Can Deliver Insulin Orally
New pill helps deliver insulin orally. The capsule is fitted with a tiny needle, coated with insulin, which is injected into the stomach wall. This could replace the need for injections in the future.

At baseline, participants with diabetes walked slower and had worse cognition than the participants without diabetes, who served as a clinical reference for a normal aging population.

Inhaled Insulin Fights Against Forgetfulness

Insulin Resistance Doubles the Risk of Major Depressive Disorder
Insulin-resistant individual has almost double the chance of developing major depressive disorder when compared to those who are not insulin-resistant.

Researchers enrolled 223 participants aged 50-85 years old with and without diabetes and assessed their normal and dual-task walking speeds, attention, memory and executive function, and mood using a battery of validated tests.

Half of the participants with diabetes and half without diabetes were treated with insulin delivered intranasally via an electronic atomizer once daily. The control participants were given an inactive placebo (sterile saline) intranasally.

After 24 weeks of treatment participants with diabetes who received INI had faster walking speed during treatment and post-treatment than participants with diabetes who received a placebo.

The INI-treated participants with diabetes also demonstrated increased cerebral blood flow in the frontal lobe, and lower plasma insulin and insulin resistance compared with the placebo group, while the INI-treated participants without diabetes showed improved decision-making and verbal memory.

The consistency of the trends in the data carries great implications for potential early intervention using INI to prevent or slow down the progression toward Alzheimer disease’s related dementia.

With the increasing number of younger people having prediabetes, this finding on the beneficial effect of INI deserves more attention and definitive confirmation in a larger trial.

The treatment was not associated with any serious or moderate adverse events. Intranasal insulin treatment was safe in participants with type 2 diabetes treated with subcutaneous insulins.

Source-Medindia